Military Industrial Complex Logo

Mylan Pharmaceuticals, Incorporated Contract Details



Defense contract under the Defense Logistics Agency awarded to Mylan Pharmaceuticals, Incorporated on 9/13/2016.

Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater.


The contract language is EXACTLY as it appears on the official U.S. DoD website (http://www.defense.gov/contracts/) unless otherwise noted.




Contractor: Mylan Pharmaceuticals, Incorporated
Department: Defense Logistics Agency
Awarded: 9/13/2016


Mylan Pharmaceuticals Inc., Morgantown, West Virginia, has been awarded a maximum $121,498,093 firm-fixed-price requirements contract for the Lidocaine five percent patch. This was a competitive acquisition with four responses received. This is a one-year base contract with four one-year option periods. Locations of performance are West Virginia, Vermont, and North Carolina, with a Sept. 12, 2021, performance completion date. Using customers are Department of Defense, Department of Veterans Affairs, Indian Health Services, and Federal Bureau of Prisons. Type of appropriation is fiscal 2017 through fiscal 2021 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2D2-16-D-0042).


Total Contract Value: $121,498,093


View all contracts that include "Mylan Pharmaceuticals, Incorporated" in the MiC database.